Pure Financial Advisors LLC Has $2.53 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Pure Financial Advisors LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 31.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,831 shares of the healthcare conglomerate’s stock after buying an additional 1,157 shares during the quarter. Pure Financial Advisors LLC’s holdings in UnitedHealth Group were worth $2,530,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the business. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in UnitedHealth Group in the fourth quarter worth about $26,000. Hurley Capital LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at about $28,000. Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. Finally, Promus Capital LLC bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $32,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 1.1%

NYSE UNH opened at $302.19 on Thursday. The company has a market cap of $274.13 billion, a PE ratio of 12.65, a PEG ratio of 1.45 and a beta of 0.44. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The stock has a 50 day moving average of $342.22 and a 200-day moving average of $458.07. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period in the previous year, the company posted $6.91 earnings per share. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a $2.21 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 2.93%. The ex-dividend date was Monday, June 16th. UnitedHealth Group’s payout ratio is currently 37.02%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on UNH shares. Truist Financial restated a “buy” rating and issued a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. TD Securities restated a “hold” rating and set a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. TD Cowen lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective on the stock. in a research note on Monday, May 19th. Baird R W lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 11th. Finally, Piper Sandler lowered their price objective on shares of UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a research report on Tuesday, June 3rd. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $415.57.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction on Wednesday, May 14th. The shares were purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director now directly owns 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer now owns 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders purchased 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.